Status:
COMPLETED
Patient Satisfaction and Long-term Safety of Intravesical Aminoglycoside Instillations in UTI Prevention
Lead Sponsor:
Leiden University Medical Center
Conditions:
Urinary Tract Infections
Recurrent Urinary Tract Infection
Eligibility:
All Genders
18+ years
Brief Summary
Antimicrobial prophylactic treatment of recurrent UTI is limited by emerging resistance, antibiotic allergies and intolerances. Intravesical aminoglycoside instillations (IAI) have been shown to reduc...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Currently receiving or having received (no minimal duration) continuous or post-coital IAI (gentamicin, tobramycin or amikacin) for recurrent UTI prophylaxis and treatment
Exclusion
- Exclusively receiving IAI for 'on-demand' treatment of UTI and not prophylactic purposes
- Receiving IAI as suppressive therapy for chronic prostatitis
- Presence of a chronic indwelling catheter
- Patient has objected to the use of his/her data
- Inability to provide informed consent
Key Trial Info
Start Date :
April 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 7 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05376670
Start Date
April 20 2022
End Date
March 7 2023
Last Update
March 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leiden University Medical Center
Leiden, South Holland, Netherlands, 2333 ZA